InvestorsHub Logo
Followers 53
Posts 3618
Boards Moderated 0
Alias Born 06/07/2011

Re: railroadman post# 11169

Sunday, 03/06/2016 6:21:59 AM

Sunday, March 06, 2016 6:21:59 AM

Post# of 12450
According to a 6-K filed by Redhill Biopharma March 2nd. 2016, they will be filing the new NDA for Rizaport (the migraine drug) in the 4th. quarter of 2016. That will bring approval out to the 2nd. half of 2017. I wouldn't expect any sales until early 2018 at best.

http://www.sec.gov/Archives/edgar/data/1553846/000117184316008269/exh_991.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News